Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00710619 · ClinicalTrials.gov registry record
Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX
A clinical trial, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- 52
- Enrollment target
NCT00710619: Completed study, sponsored by Novo Nordisk A/S.
NCT00710619 is a clinical trial that has completed, run by Novo Nordisk A/S. The registered enrollment target is 52 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00710619 has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
This study is conducted in the United States of America (USA). The aim of this study is to investigate the at-home-administration of bypassing agents for treatment of bleeding episodes in patients with congenital haemophilia with inhibitors to factors VIII and IX. We are further investigating how bleeding episodes affect the quality of life of the patient and their family or caregivers.
Interventions
- DRUG activated recombinant human factor VII
- DRUG Feiba VH
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2008-06 |
| Est. Completion | 2009-07 |
What the finished NCT00710619 record still lists
NCT00710619 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which activated recombinant human factor VII is the first listed.
NCT00710619 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00710619 about?
NCT00710619 is a clinical study titled "Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX". This study is conducted in the United States of America (USA). The aim of this study is to investigate the at-home-administration of bypassing agents for treatment of bleeding episodes in patients with congenital haemophilia with inhibitors to factors VIII and IX. We are further investigating how bl...
What is the current status of trial NCT00710619?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2008-06. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00710619?
The interventions under investigation include: activated recombinant human factor VII (DRUG), Feiba VH (DRUG).
Who is sponsoring clinical trial NCT00710619?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia